Back

Clinical characteristics predisposing to appropiate ventricular therapy in patients with implanted cardioverter-defibrilator for primary prevention of sudden cardiac death.

18 June 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Sudden cardiac death and implantable defibrillators Primary prevention (Sudden cardiac death and implantable defibrillators) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Doctor Francisco Mendez Zurita

Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)

20 More presentations in this session

Presentation thumbnail
Prospective study of implantable cardioverter-defibrillator activation in hypertrophic cardiomyopathy patients in greece
Doctor P. Dilaveris (Athens, GR)
Abstract
Presentation thumbnail
Total cosine R-to-T for predicting ventricular arrhythmic and mortality outcomes: a systematic review and meta-analysis
Professor G. Tse (Hong Kong, CN)
Abstract
Presentation thumbnail
Proposed risk factors of sudden cardiac death in hypertrophic cardiomyopathy patients
Doctor V. Kaplunova (Moscow, RU)
Abstract Slides
Presentation thumbnail
Discrepancy in ejection fractions measured by echocardiography and magnetic resonance imaging in heart failure patients with severe left ventricular dysfunction
Professor J. Park (Busan, KR)
Abstract
Presentation thumbnail
Mid-term mortality after implantable cardioverter-defibrillator:causes and predictors
Doctor J. Acosta Martinez (Seville, ES)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Sudden cardiac death and implantable defibrillators

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources